(Reuters) - Ruane, Cunniff & Goldfarb Inc, the investment firm that runs the Sequoia Fund and once the largest shareholder of Valeant Pharmaceuticals International Inc , said it exited its position in the embattled Canadian drugmaker by mid-June.